Protech
  • Protech Home Medical (PTQ) will be presenting at The MicroCap Rodeo Winter Wonderland Conference on February 16 at 3:30 pm (EST)
  • The live webcast of the presentation will be available by visiting the investors’ section of Protech’s website
  • The MicroCap Rodeo Winter Wonderland Conference showcases 35 best ideas from companies recommended by qualified institutional investors
  • Protech Home Medical Corp provides in-home monitoring equipment, supplies, and services to patients
  • Protech Home Medical (PTQ) is up 0.80 per cent, trading at C$2.51 at 3:45 pm EST

Protech Home Medical (PTQ) will be presenting at The MicroCap Rodeo Winter Wonderland Conference on February 16 at 3:30 pm (EST).

Greg Crawford, CEO of Protech, will be presenting to a live, virtual audience.

The live webcast of the presentation will be available by visiting the investors’ section of the company’s website.

The webcast will also be available for replay on the company’s website following the event.

The MicroCap Rodeo Winter Wonderland Conference is a virtual conference showcasing 35 best ideas from companies recommended by qualified institutional investors.

Protech Home Medical (PTQ) provides in-home monitoring and disease management services including end-to-end respiratory solutions for patients in the United States healthcare market.

It seeks to continue to expand its offerings to include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility and other chronic health conditions. 

Protech Home Medical (PTQ) is up 0.80 per cent, trading at C$2.51 at 3:45 pm EST.

More From The Market Online

Telo Genomics and Emery Pharma collaborate

Telo Genomics (TSXV:TELO) collaborates with Emery Pharma to enhance cellular and molecular bioanalytical solutions for clinical research.

UniDoc brings AI to ER patients

UniDoc (CSE:UDOC) expands its AI partnership with DocBox, further integrating predictive analytics into emergency room operations.

Avicanna finishes study of CBD cream’s use for rare skin disorder

Avicanna (TSX:AVCN) completes an observational study of its RHO Phyto-branded Ultra CBD topical cream on patients with epidermolysis bullosa.